Cargando…

Trimetazidine in Practice: Review of the Clinical and Experimental Evidence

All of the following traditional agents for the management of stable angina pectoris include the symptomatic treatment with heart rate–lowering agents such as β-blockers or non-dihydropyridine Ca-channel blockers, or ivabradine—the first selective sinus node I(f) channel inhibitor—vasodilatators and...

Descripción completa

Detalles Bibliográficos
Autor principal:	Dézsi, Csaba A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Journal of Therapeutics 2016
Materias:	Therapeutic Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4856171/ https://www.ncbi.nlm.nih.gov/pubmed/25756467 http://dx.doi.org/10.1097/MJT.0000000000000180

Ejemplares similares

Differences in the Clinical Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers: A Critical Review of the Evidence
por: Dézsi, Csaba András
Publicado: (2014)

Management of dental patients receiving antiplatelet therapy or chronic oral anticoagulation: A review of the latest evidence
por: Dézsi, Csaba András, et al.
Publicado: (2017)

Trimetazidine in Heart Failure
por: Shu, Hongyang, et al.
Publicado: (2021)

Trimetazidine-Induced Parkinsonism: A Systematic Review
por: Dy, Anna Marielle B., et al.
Publicado: (2020)

Clinical effects of carvedilol and trimetazidine for the treatmentof alcoholic myocardiopathy
por: Li, Hui, et al.
Publicado: (2016)

Clarity and applicability of adverse drug reaction-related monitoring instructions in clinical practice guidelines for children and adolescents treated with antipsychotic drugs: a review of six clinical practice guidelines
por: Minjon, Lenneke, et al.
Publicado: (2022)

Meta-analysis of trimetazidine treatment for cardiomyopathy
por: Fan, Qian, et al.
Publicado: (2018)

Cardiac Effects of Trimetazidine in Diabetic Rats
por: Mansur, Alfredo J.
Publicado: (2019)

The Different Therapeutic Choices with ARBs. Which One to Give? When? Why?
por: Dézsi, Csaba András
Publicado: (2016)

Metabolic regulation to treat bipolar depression: mechanisms and targeting by trimetazidine
por: Khanra, Sourav, et al.
Publicado: (2023)

Short‐Term Efficacy Reliably Predicts Long‐Term Clinical Benefit in Rheumatoid Arthritis Clinical Trials as Demonstrated by Model‐Based Meta‐Analysis
por: Wang, Yehong, et al.
Publicado: (2015)

The International Fragile X Premutation Registry: building a resource for research and clinical trial readiness
por: Hessl, David, et al.
Publicado: (2022)

The cardioprotective role of trimetazidine on cisplatin-induced cardiotoxicity
por: Küçük, Murathan, et al.
Publicado: (2020)

Long-term multisystemic efficacy of migalastat on Fabry-associated clinical events, including renal, cardiac and cerebrovascular outcomes
por: Hughes, Derralynn A, et al.
Publicado: (2023)

Clinical Efficacy of Trimetazidine and Holistic Management in the Treatment of Coronary Heart Disease
por: QU, Li, et al.
Publicado: (2018)

Clinical Acceptability Of Trimetazidine Modified-Release 80 mg Once Daily Versus Trimetazidine Modified-Release 35 mg Twice Daily In Stable Angina Pectoris
por: Pozdnyakov, Yuri M.
Publicado: (2018)

Review of the Emerging Evidence Demonstrating the Efficacy of Ivermectin in the Prophylaxis and Treatment of COVID-19
por: Kory, Pierre, et al.
Publicado: (2021)

The effects of trimetazidine on lipopolysaccharide-induced oxidative stress in mice
por: Abdel-Salam, Omar M.E., et al.
Publicado: (2011)

Bisphosphonates and evidence for association with esophageal and gastric cancer: a systematic review and meta-analysis
por: Wright, Ellen, et al.
Publicado: (2015)

Reviewing Evidence for the Usefulness of Family Interventions for Depression During and After the COVID-19 Pandemic
por: Keitner, G.
Publicado: (2022)

Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers on Prothrombotic Processes and Myocardial Infarction Risk
por: Dézsi, Csaba András, et al.
Publicado: (2016)

The Real Role of β-Blockers in Daily Cardiovascular Therapy
por: Dézsi, Csaba András, et al.
Publicado: (2017)

Clinical Outcome Data of First Cohort of Chronic Pain Patients Treated With Cannabis‐Based Sublingual Oils in the United Kingdom: Analysis From the UK Medical Cannabis Registry
por: Kawka, Michal, et al.
Publicado: (2021)

Behaviour change interventions to promote prescribing of generic drugs: a rapid evidence synthesis and systematic review
por: Moe-Byrne, Thirimon, et al.
Publicado: (2014)

Metabolic manipulation in dilated cardiomyopathy: Assessing the role of trimetazidine
por: Jatain, Suman, et al.
Publicado: (2016)

The effect of oral and intraurethral trimetazidine use on urethral healing
por: Ayyildiz, Ali, et al.
Publicado: (2016)

Antipsychotic-Like Effect of Trimetazidine in a Rodent Model
por: Erbaş, Oytun, et al.
Publicado: (2013)

Metabolic manipulation in Dilated Cardiomyopathy: assessing the role of trimetazidine
por: Kapoor, Aditya, et al.
Publicado: (2015)

Is Treatment with Trimetazidine Beneficial in Patients with Chronic Heart Failure?
por: Zhou, Xiang, et al.
Publicado: (2014)

Trimetazidine Use in Parkinson’s Disease: Is It a Resolved Problem?
por: Pintér, Dávid, et al.
Publicado: (2021)

Microenvironmental adaptation of experimental tumours to chronic vs acute hypoxia
por: Thews, O, et al.
Publicado: (2004)

Bombesin antagonists inhibit proangiogenic factors in human experimental breast cancers
por: Bajo, A M, et al.
Publicado: (2004)

Statistical Primer on Biosimilar Clinical Development
por: Isakov, Leah, et al.
Publicado: (2016)

Expression of the ubiquitin-proteasome pathway and muscle loss in experimental cancer cachexia
por: Khal, J, et al.
Publicado: (2005)

Combinatorial experimental protocols for Erbicin-derived immunoagents and Herceptin
por: De Lorenzo, C, et al.
Publicado: (2007)

Ticagrelor: Pharmacokinetics, Pharmacodynamics, Clinical Efficacy, and Safety
por: Dobesh, Paul P, et al.
Publicado: (2014)

Efficacy of Cefiderocol in Experimental Stenotrophomonas maltophilia Pneumonia in Persistently Neutropenic Rabbits
por: Petraitis, Vidmantas, et al.
Publicado: (2022)

Gut microbiome health and dysbiosis: A clinical primer
por: Bidell, Monique R., et al.
Publicado: (2022)

Buprenorphine initiation strategies for opioid use disorder and pain management: A systematic review
por: Spreen, Lauren A., et al.
Publicado: (2022)

Thiram inhibits angiogenesis and slows the development of experimental tumours in mice
por: Marikovsky, M
Publicado: (2002)

Cannot write session to /tmp/vufind_sessions/sess_et336d6nld27mkvt5lh4b0lbjs